Latest Breaking News On - Global medical affairs - Page 5 : comparemela.com

New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups

New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Lebanon
New-jersey
United-states
United-arab-emirates
Ireland
Denmark
Finland
China
Dublin
United-kingdom
Spain
Canada

Bayer unveils medical breakthroughs

Bayer is set to embark on its next phase of growth with a new wave of medical breakthroughs.

Vietnam
Republic-of
Christian-rommel
Dominik-ruettinger
Stefan-oelrich
Cecilia-caetano
Bayer-pharmaceuticals-division
Committee-of-bayer-pharmaceuticals-division
Early-development-for-oncology-at-bayer
Pharma-media-day
Global-medical-affairs
Early-development

REDUCE-IT Lp(a) Analysis Details Icosapent Ethyl Effect on MACE Across Lp(a) Range

A REDUCE-IT analysis highlights consistent cardiovascular benefits with icosapent ethyl across varying levels of Lp(a).

United-states
American
Harpreet-bhatia
Philippe-gabriel-steg
Nabil-abadir
Coll-cardiol
Michael-blaha
Division-of-cardiovascular-medicine
American-heart-association
Johns-hopkins-ciccarone-center
Research-evaluating
Global-medical-affairs-at-amarin

Vision Research Funding Partnership Event Takes Place Today

Leaders of organizations that fund vision research convene in Washington, D.C. to increase collaboration and maximize the impact of research funding for sight-t

Michigan
United-states
Washington
American
Brian-hofland
Calvin-roberts
Dan-ignaszewski
Michael-chiang
Fredericka-davis
Robert-levine
Sheila-hickson-curran
Aaron-nicholls

Research Evaluating Benefits of VASCEPA/VAZKEPA (icosapent ethyl) to be Presented at the American College of Cardiology's (ACC) Annual Scientific Session & Expo Seite 1

25.03.2024 - - Subgroup Analyses from REDUCE-IT and Mechanistic Data on Icosapent Ethyl(IPE)/Eicosapentaenoic Acid (EPA) Featured at the Meeting - DUBLIN, Ireland and BRIDGEWATER, N.J., March 25, 2024 (GLOBE NEWSWIRE) - Amarin Corporation plc (NASDAQ:AMRN) . Seite 1

Michael-miller
Elliota-brinton
Nabil-abadir
Deepakl-bhatt
Head-of-global-medical-affairs-at-amarin
Chief-medical-officer
Global-medical-affairs
Available-april
Moderated-poster-theater
Amarin-chart
Marin-kurs
Marin-aktie